DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | 0.0% | 266 | +88.7% | 0.00% | – |
| Q2 2021 | $5,000 | +25.0% | 141 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 141 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -62.5% | 141 | -66.6% | 0.00% | – |
| Q3 2020 | $8,000 | +14.3% | 422 | +9.3% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 386 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 386 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +50.0% | 386 | -11.5% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 436 | +9.3% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 399 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | 0.0% | 399 | -33.5% | 0.00% | – |
| Q4 2018 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
| Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
| EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
| RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
| BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
| Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
| Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
| DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
| EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |